Advertisement

ADVERTISEMENT

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Clinical Pathways GPS
The Future of Medicare…Medicare Managed Care
03/16/2022
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Richard G Stefanacci, DO, MGH, MBA, explains why it is highly likely that Medicare managed care will represent over half of the Medicare market in the next year and, therefore, become a leader not only for Medicare care but also a guide for...
Richard G Stefanacci, DO, MGH, MBA, explains why it is highly likely that Medicare managed care will represent over half of the Medicare market in the next year and, therefore, become a leader not only for Medicare care but also a guide for...
Richard G Stefanacci, DO, MGH,...
03/16/2022
Journal of Clinical Pathways
Clinical Pathways GPS
Digital Health Placement in Clinical Pathways
12/16/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Brian C Abraham, MPA
Martin Culjat, PhD
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
The...
12/16/2020
Journal of Clinical Pathways
Clinical Pathways GPS
Making the Case for Genetic Testing in Clinical Pathways
10/21/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing literature...
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing literature...
...
10/21/2020
Journal of Clinical Pathways
Population Health Partnerships to Advance Value-Based Care
Clinical Pathways GPS
Population Health Partnerships to Advance Value-Based Care
09/18/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
The business model for health care in the United States is evolving from a volume-driven model to a consumer-centric, value-driven model. As such, there are new competencies required of hospitals and health systems...
The business model for health care in the United States is evolving from a volume-driven model to a consumer-centric, value-driven model. As such, there are new competencies required of hospitals and health systems...
The...
09/18/2020
Journal of Clinical Pathways
Government Involvement in Direct Utilization Management, Push for Value-Based Approaches
Clinical Pathways GPS
Government Involvement in Direct Utilization Management, Push for Value-Based Approaches
08/19/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Physicians are being forced to the weigh risks vs benefits of previously routine treatments and procedures in light of capacity concerns and COVID infection risk. While Medicare fee-for-service has historically had...
Physicians are being forced to the weigh risks vs benefits of previously routine treatments and procedures in light of capacity concerns and COVID infection risk. While Medicare fee-for-service has historically had...
...
08/19/2020
Journal of Clinical Pathways
Where Health Systems Are in the Shift to Value: Four Categories
Clinical Pathways GPS
Where Health Systems Are in the Shift to Value: Four Categories
06/17/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health...
One could make the argument that there are four situational categories under which all health systems now fall on the journey toward more value-based care and away from the fee-for-service model. Assisting health...
One...
06/17/2020
Journal of Clinical Pathways
How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery
Clinical Pathways GPS
How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery
05/19/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...
Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...
...
05/19/2020
Journal of Clinical Pathways
Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease
Clinical Pathways GPS
Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease
03/16/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Matthew Pakizegee, PharmD, MS
Jonathan W Hodgson, MBA
Chad McAuliffe
Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...
Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...
...
03/16/2020
Journal of Clinical Pathways
Clinical Pathways GPS
Federal Enforcement of Clinical Pathways, Resource Utilization Management
09/20/2019
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Providers order unnecessary tests for a variety of reasons: pressure from patients, fears of malpractice suit, not being knowledgeable about current “best” practices as well as for potential financial advantage for...
Providers order unnecessary tests for a variety of reasons: pressure from patients, fears of malpractice suit, not being knowledgeable about current “best” practices as well as for potential financial advantage for...
...
09/20/2019
Journal of Clinical Pathways
Clinical Pathways GPS
How the Proposed Elimination of Medicare Rebates Would Impact Clinical Pathways
11/18/2018
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
The Centers for Medicare & Medicaid Services (CMS) has published a range of new proposed and final rules regarding payment rates and policies affecting providers, payers, and patients. The Trump administration...
The Centers for Medicare & Medicaid Services (CMS) has published a range of new proposed and final rules regarding payment rates and policies affecting providers, payers, and patients. The Trump administration...
The...
11/18/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use